SCHEMBL5769720

SCHEMBL5769720

CCN(CCNC(=O)OC(C)(C)C)c1ccccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 1/20 0.43
SKP1 P63208 1/20 0.43
SKP2 Q13309 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 2/20 0.43
TSHR P16473 1/20 0.43
DRD2 P14416 3/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HPGD P15428 1/20 0.41
IDO1 P14902 3/20 0.41
MALT1 Q9UDY8 1/20 0.41
BCHE P06276 1/20 0.40
STK17B O94768 1/20 0.40
STK17A Q9UEE5 1/20 0.40
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8399559 0.82 MAPT (0.54) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL26313896 0.81 IDO1 (0.45) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL26313798 0.78 IDO1 (0.43) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL30597303 0.78 IDO1 (0.43) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL18918089 0.75 MEN1 (0.50) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL1433076 0.74 MAPT (0.49) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL8747512 0.74 KMT2A (0.50) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL31117833 0.74 CKS1B (0.45) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL3722147 0.74 DRD2 (0.46) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL11744842 0.74 IDO1 (0.42) CKS1BSKP1SKP2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1638944-A1 TACHYKININ RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2006-03-29 EP disclosed
WO-2005000821-A1 TACHYKININ RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2005-01-06 WO disclosed